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ABSTRACT Escherichia coli sequence type 131 (ST131) has emerged globally as the most predominant extraintestinal patho-
genic lineage within this clinically important species, and its association with fluoroquinolone and extended-spectrum cephalo-
sporin resistance impacts significantly on treatment. The evolutionary histories of this lineage, and of important antimicrobial
resistance elements within it, remain unclearly defined. This study of the largest worldwide collection (n 215) of sequenced
ST131 E. coli isolates to date demonstrates that the clonal expansion of two previously recognized antimicrobial-resistant clades,
C1/H30R and C2/H30Rx, started around 25 years ago, consistent with the widespread introduction of fluoroquinolones and
extended-spectrum cephalosporins in clinical medicine. These two clades appear to have emerged in the United States, with the
expansion of the C2/H30Rx clade driven by the acquisition of a blaCTX-M-15-containing IncFII-like plasmid that has subsequently
undergone extensive rearrangement. Several other evolutionary processes influencing the trajectory of this drug-resistant lin-
eage are described, including sporadic acquisitions of CTX-M resistance plasmids and chromosomal integration of blaCTX-M
within subclusters followed by vertical evolution. These processes are also occurring for another family of CTX-M gene variants
more recently observed among ST131, the blaCTX-M-14/14-like group. The complexity of the evolutionary history of ST131 has im-
portant implications for antimicrobial resistance surveillance, epidemiological analysis, and control of emerging clinical lin-
eages of E. coli. These data also highlight the global imperative to reduce specific antibiotic selection pressures and demonstrate
the important and varied roles played by plasmids and other mobile genetic elements in the perpetuation of antimicrobial resis-
tance within lineages.
IMPORTANCE Escherichia coli, perennially a major bacterial pathogen, is becoming increasingly difficult to manage due to
emerging resistance to all preferred antimicrobials. Resistance is concentrated within specific E. coli lineages, such as sequence
type 131 (ST131). Clarification of the genetic basis for clonally associated resistance is key to devising intervention strategies. We
used high-resolution genomic analysis of a large global collection of ST131 isolates to define the evolutionary history of
extended-spectrum beta-lactamase production in ST131. We documented diverse contributory genetic processes, including sta-
ble chromosomal integrations of resistance genes, persistence and evolution of mobile resistance elements within sublineages,
and sporadic acquisition of different resistance elements. Both global distribution and regional segregation were evident. The
diversity of resistance element acquisition and propagation within ST131 indicates a need for control and surveillance strategies
that target both bacterial strains andmobile genetic elements.
Received 22 December 2015 Accepted 25 February 2016 Published 22 March 2016
Citation Stoesser N, Sheppard AE, Pankhurst L, De Maio N, Moore CE, Sebra R, Turner P, Anson LW, Kasarskis A, Batty EM, Kos V, Wilson DJ, Phetsouvanh R, Wyllie D, Sokurenko
E, Manges AR, Johnson TJ, Price LB, Peto TEA, Johnson JR, Didelot X, Walker AS, Crook DW, Modernizing Medical Microbiology Informatics Group (MMMIG). 2016. Evolutionary
history of the global emergence of the Escherichia coli epidemic clone ST131. mBio 7(2):e02162-15. doi:10.1128/mBio.02162-15.
Invited Editor David A. Rasko, University of Maryland School of Medicine Editor Paul Stephen Keim, Northern Arizona University
Copyright © 2016 Stoesser et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license.
Address correspondence to Nicole Stoesser, nicole.stoesser@ndm.ox.ac.uk.
Resistance to extended-spectrum cephalosporins in extraintes-tinal pathogenic Escherichia coli (ExPEC) represents a major
clinical challenge and is commonly caused by the presence of
extended-spectrum beta-lactamases (ESBLs). The majority of
ESBL-associated E. coli infections are due to a recently emerged,
globally distributed ExPEC clone, sequence type 131 (ST131) (1).
ST131 predominantly corresponds to serogroup O25b (2, 3) or
O16 (4) and belongs to phylogenetic group B2 (5, 6). It remains
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unclear which features of this clone have resulted in its recent
widespread clinical dominance, although antimicrobial resistance
and virulence factors are suspected contributors (7).
The blaCTX-M-15 beta-lactamase gene is the dominant ESBL
gene in ST131, but other genetically divergent CTX-M genes also
occur in this ST, particularly blaCTX-M-14/14-like variants, e.g., in
Canada, China, and Spain (8, 9). The almost contemporaneous
identification of blaCTX-M in ST131 strains from multiple geo-
graphic locations suggests repeated acquisition via multiple hori-
zontal gene transfer events (10). Consistently, both blaCTX-M-15
and blaCTX-M-14/14-like variants occur on conjugative plasmids, es-
pecially multireplicon IncFII plasmids additionally harboring
FIA/FIB replicons (11).
Other data, however, suggest that the widespread distribution
of these genes is mediated by clonal expansion of CTX-M-
containing strains and global dissemination (12). This is also a
plausible hypothesis, since CTX-M plasmids can be inherited sta-
bly and blaCTX-M-15 and blaCTX-M-14 variants can also integrate
into the chromosome (13–15). Nevertheless, clonal expansion of
E. coli strains with chromosomally integrated blaCTX-M has not yet
been demonstrated.
Two recent studies used whole-genome sequence (WGS) data
to investigate the population structure of ST131. The first found
that ST131 expansion in the United States has been driven by a
single sublineage, H30, defined by the presence of a specific fim-
brial adhesin allele, fimH30. Within H30, nested clades have
emerged:H30R, containing mutations in the chromosomal genes
gyrA and parC that confer fluoroquinolone resistance, and
H30Rx, containing the same gyrA and parC mutations but addi-
tionally associated with blaCTX-M-15 (13). The second study (16),
which included samples from six locations around the world, re-
solved the ST131 population structure into three clades, A, B, and
C, with clade C comprising two subgroups, C1 and C2, corre-
sponding to the H30R and H30Rx clades. However, this study
included only four isolates from Asia, where ESBL ExPEC preva-
lence may be highest (17, 18). Furthermore, neither study directly
tested the competing hypotheses that ESBL dissemination in
ST131 has occurred through multiple horizontal gene transfer
events versus clonal expansion.
Here, we used a broader set of ST131 WGS data, including
many more isolates from Asia and blaCTX-M-14/14-like-containing
strains, alongside a subset of CTX-M plasmid sequences, to esti-
mate the contribution of each potential route of dissemination to
the worldwide prevalence of ST131.
RESULTS
The 215 ST131 genome sequences analyzed included 67 strains
from various locations in Southeast Asia, 33 from Oxford in the
United Kingdom, 11 from a global resistance surveillance pro-
gram at AstraZeneca, 8 from Canada, and 96 predominantly
North American isolates previously reported by Price et al. (13)
(details on new isolates are shown in Table S1 in the supplemental
material; these strains included both human and animal isolates
and clinical and carriage isolates.)
Asian ST131 strains are consistent with the previously de-
scribed core phylogeny, and the C1/H30 and C2/H30Rx clades
emerged from a North American ancestor. For the 4,717,338
sites in the SE15 ST131 reference genome (19), themeanmapping
call rate across the data set was 93.3%. In total, 40,057 (0.85%)
sites were variable, with 6,879 (0.15%) representing core single-
nucleotide variants (SNVs) called in all 215 isolates. Overall,
611,770 (13%) sites were in recombinant regions, including 4,120
core SNVs, leaving 2,759 core nonrecombinant SNVs for phylo-
genetic analysis.
Consistent with the two previous WGS-based ST131 phylog-
enies (13, 16), the time-scaled phylogeny inferred from this ST131
data set (which included10 times more Asian isolates than con-
sidered previously) comprised three clades (Fig. 1), A (n 25), B
(n 51), and C (n 139), with C containing two subclades, C1
(n  57) and C2 (n  82), characterized by the presence versus
absence, respectively, of blaCTX-M-15 (16). Isolates from all geo-
graphic regions were identified within each clade, although there
were smaller, geographically restricted clusters within these
(Fig. 1, tip color). This supports both global transmission and
localized lineage expansion following specific introductions into a
geographic locality.
The estimated time to most recent common ancestor (TM-
RCA) for the whole genomic data set was ~130 years ago, when
clade A diverged from clades B andC. Twenty-five years ago, clade
C emerged out of the paraphyletic clade B, which was quickly
followed by the split between subclades C1 andC2. The number of
core SNVs separating the cladeswas approximately 250 for cladeA
versus clades B andC, 50 to 60 for clade B versus clades C1 andC2,
and 10 to 30 for clade C1 versus clade C2. The evolutionary rate of
ST131 was estimated in BEAST (see Materials and Methods) at
2.46 107 mutations per site per year (95% confidence interval
[CI], 2.18 107 to 2.75 107), equating to 1.00 (95%CI, 0.89
to 1.12) mutation per genome per year.
All possible geographic origins of the root of the ST131 lineage
were inferred to be equally likely since the root is far back in time
relative to the estimated migration rates. Clade A was inferred to
originate in Southeast Asia with ~70% confidence (78%when the
unsampled deme was included in the model [see Materials and
Methods]), and the B/C clades were inferred to originate from
North America with ~88% confidence. The ancestral origin of
C1/H30 and C2/H30Rx was strongly inferred as being in North
America (98% confidence; 85% confidence when the unsampled
deme was included in the model) with subsequent dissemination
to Europe and Asia. Locations of more recent nodes are inferred
with high confidence, as expected (20).
blaCTX-M, fimH, and gyrA variants are strongly associated
with specific ST131 clades.Overall, 105 (49%)ST131 isolates har-
bored blaCTX-M, including 74 isolates (34%) with blaCTX-M-15, 20
(9%) with blaCTX-M-14, 8 (4%) with blaCTX-M-27, and one each
(0.4%) with blaCTX-M-19, blaCTX-M-24, and blaCTX-M-55 (Fig. 1).
blaCTX-M-15 was almost completely restricted to the C2 clade, as
described previously (16), occurring in 69/82 (84%) C2 isolates
but only sporadically in other clades (4/133; P  0.001, Fisher
exact test). blaCTX-M-14 and blaCTX-M-27 were also clustered within
the two different clades A and C1 and absent from B and C2
(Fig. 1). Overall, the presence of shared blaCTX-M variants within
clusters was constrained to those with a TMRCA of less than
25 years, suggestive of the emergence of blaCTX-M within ST131
after the widespread introduction of extended-spectrum cephalo-
sporins in clinical practice.
The most common fimH variant was fimH30 (n 123; 57%),
followed by fimH22 (n  24; 11%) and fimH41 (n  21; 10%),
whereas 23 isolates had novel fimH variants, and one was fimH
null. As observed for blaCTX-M, fimH alleles were strongly associ-
ated with clade, with 21/25 (84%) isolates in clade A having
Stoesser et al.
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fimH41, 23/51 (45%) in clade B having fimH22, and 122/139
(88%) in clade C having fimH30 (P 0.001; Fisher exact test).
Fluoroquinolone resistance mutations in gyrA and parC were
also clade associated, with isolates in clades A and B typically hav-
ing no or only single mutations in these genes’ quinolone
resistance-determining regions (QRDRs) (Fig. 1). In contrast,
most cladeC isolates had doublemutations in both gyrA and parC,
shown to confer high-level fluoroquinolone resistance (21) (132/
FIG 1 Time-scaled phylogeny of ST131 E. coli (n  215), with associated blaCTX-M/fimH variants, and quinolone resistance-determining region (QRDR)
mutations in gyrA (WT, wild-type QRDR). Curly brackets represent ST131 clades as described in the text. Tips are colored by geographic region, per the key. T,
blaCTX-M plasmid transformant generated for strain; *, cases with putative deletions in the assembled blaCTX-M-15 gene.
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139 [95%]). The seven clade C isolates without thesemutations (5
in C1 and 2 in C2) were sporadic, with two having non-fimH30
variants, suggesting intermittent recombination events affecting
gyrA, parC, and fimH. The emergence of this double-mutation,
high-level fluoroquinolone resistance genotype was dated by our
methods to 25 to 40 years ago, consistent with the introduction of
fluoroquinolones in clinical practice.
blaCTX-M-15 in clade C2 is present in a consistent but short
flanking structure, frequently truncated by IS26 elements and
within different genetic backgrounds. In four of the 74 blaCTX-M-15-
containing isolates,blaCTX-M-15was present on twodifferent contigs
(C1353, JJ2643, CD358, and JJ2434). In another isolate (JJ2547),
the assembled contig with blaCTX-M-15 contained a series of N’s,
suggesting possible uncertainty around the contig assembly or
multiple locations of the gene. These five isolates were excluded
from further analysis of flanking regions. In the 69 remaining isolates
(3 in clade A, 1 in clade C1, and 65 in clade C2), blaCTX-M-15 was
found downstream of a homologous tract of 48 bp preceded by an
ISEcp1 right-end inverted repeat region (IRR-R) and upstream of
a homologous tract of 46 bp followed by ORF477. This is consis-
tent with the introduction of an ISEcp1-blaCTX-M-15-ORF477 unit
within ST131 and subsequent rearrangement events affecting this
structure.
In clade C2, blaCTX-M-15 was integrated into the chromosome
of 8/65 (12%) isolates, with four unique integration events, one of
which was stably present in a subcluster of five isolates with a
common ancestor around 2002 and spread across two geograph-
ical regions (Fig. 2). All chromosomal integration events were as-
sociated with an intact ISEcp1 upstream of blaCTX-M-15. In three
isolates, the ISEcp1-blaCTX-M-15-ORF477 unit was flanked by 5-bp
target site duplications consistent with transposition, and in one
isolate, the ORF477 was truncated, suggestive of either one-ended
transposition (22) or standard transposition followed by a dele-
tion event (Fig. 2).
In 27 of the 57 remaining C2 isolates, blaCTX-M-15 appeared
plasmid associated, being either present in plasmid transformants
(n 20) or flanked by likely plasmid-associated sequences in the
contig assemblies (n 7). In the remaining 30 isolates, the loca-
tion of blaCTX-M-15 could not be defined due to limitations of the
short-read assemblies. In all 57 isolates, the upstream sequence
was either an intact or truncated ISEcp1 sequence, and in 51/57
(89%) isolates, the sequence downstreamofORF477was either an
intact or a truncated Tn2 structure (Fig. 3). In 12 isolates distrib-
uted throughout cladeC2, a continuation of the Tn2 sequencewas
also observed upstream of the ISEcp1 sequence, consistent with
the ISEcp1 element (flanked by a pair of 5-bp repeats, all TCATA)
being nested within a complete or partial Tn2 transposon. In
40/57 (65%) isolates, IS26 repeat regions truncated either or both
of these upstream and downstream contexts (Fig. 3).
blaCTX-M-14 and blaCTX-M-27 are present in diverse genetic
backgrounds and within a common ISEcp1-IS903B transposi-
tion unit. For blaCTX-M-14, evidence of chromosomal integration
FIG 2 Chromosomal location of ISEcp1-mediated blaCTX-M-15 insertion events and evidence of acquisition and evolution by descent (inset phylogeny) over
approximately 8 years across two geographic regions (Oxford, United Kingdom; Mae Sot, Thailand-Myanmar border). Coloring of isolate names represents
geographic location (red, Europe; green, Southeast Asia; blue, North America).
Stoesser et al.
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FIG 3 Genetic flanking context of blaCTX-M-15 region for clade C2/H30Rx isolates. (Top) Putative source element. (Left) C2/H30Rx phylogeny. Many contexts
are limited by the extent of the assembled region around the blaCTX-M-15 gene (marked with “X”). For all similarly colored, vertically aligned regions below the
“Putative source element,” sequence identity is 100%.Curly brackets cluster those isolates with identical flanking sequences. Flanking contexts are not shown and
tip labels are omitted for isolates with known chromosomal integration of blaCTX-M, for blaCTX-M-negative isolates in the clade, or for isolates where the flanking
sequence was not evaluable (see Results).
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was also found: two related blaCTX-M-14 isolates had ISEcp1-
mediated chromosomal integration of blaCTX-M-14 downstream of
the gatY gene (clade A, isolates HFMK328 and HFMK347). Six
isolates had plasmid-associated blaCTX-M-14 based on annotated
flanking sequences/transformants, whereas for the rest (n  14),
the location of blaCTX-M-14 was uncertain due to limitations of the
de novo assemblies.
In all these isolates, ISEcp1 was consistently located upstream
of blaCTX-M-14, as with blaCTX-M-15, but at only a 43-bp distance,
and the downstream flanking sequences were composed of either
intact or truncated IS903B elements. In clade A, the genetic flank-
ing sequences surrounding blaCTX-M-14 were consistent with the
host strain subcluster and were homologous over the observed
contig length within this subcluster (see Fig. S1 in the supplemen-
tal material, clade A CTX-M-14 subcluster [i]). This supports a
single blaCTX-M-14 plasmid acquisition event followed by either
evolution with plasmid inheritance or subsequent transfer of a
blaCTX-M-14-containing genetic unit within the subcluster. The
flanking sequence for isolate la_5108_T in clade C1 also incorpo-
rated an ISEc23 element downstream of IS903B and was homolo-
gous to that in clade A CTX-M-14 subcluster [i] (see Fig. S2),
suggesting horizontal transfer of this genetic unit between clades.
Six of eight isolates with blaCTX-M-27 were closely related in
clade C1, again supporting a single plasmid acquisition event.
However, they also all contained bilateral truncation of the
ISEcp1-blaCTX-M-IS903B structure by IS26 elements, which oc-
curred in four different contexts, suggesting frequent IS26-
mediated blaCTX-M-27 transposition events within this subcluster
(see Fig. S2 in the supplemental material).
Plasmid replicon analysis demonstrates a degree of clade-
associated plasmid segregation suggestive of ancient IncF plas-
mid acquisition events. The predominant replicon family was
IncF, identified in 206/215 ST131 isolates (96%). Specific IncF
variants differed in frequency, with FII found in 199/215 isolates
(93%), FIB in 155/215 (72%), FIA in 145/215 (67%), and FIC in
17/215 (8%). Specific IncF replicons and combinations thereof
were clade associated (Table 1). A number of non-F Inc types were
also identified; of these, IncHwas associated with clade B and IncI
was associated with clade C1 (Table 1). Col-like plasmids were
also common (189/215 isolates [88%]); however, there was no
clear association of any Col type with clade (see Fig. S3 in the
supplemental material).
A specific FII variant (GenBank nucleotide sequence accession
no. AY458016; pC15-1a; consistent with pMLST allele 2) was sig-
nificantly associated with clade C2 (48/82 C2 isolates versus 18/
153 non-C2 isolates, P  0.001, Fisher exact test). Within clade
C2, a further 23 isolates had eight different FII_AY458016-like
variants containing up to 12 SNVs among them; almost all of these
variants were in isolates with FIA-FIB-FII replicon combinations
(see Fig. S3 in the supplemental material). Of the 11 clade C2
isolates without FII_AY458016-like replicon variants, four con-
tained a plasmid with a different FII replicon (GenBank nucleo-
tide sequence accession no. AJ851089; pRSB107, 35 SNVs differ-
ent from FII_AY458016; consistent with pMLST allele 1), five had
chromosomally integrated blaCTX-M-15 (of which four also con-
tained an FII_AJ851089-like plasmid), onewas blaCTX-Mnegative,
and one contained deletions in blaCTX-M-15. There were only nine
clade C2 isolates with FII_AY458016-like replicons but no blaCTX-
M-15. The different FII replicon associated with blaCTX-M-15 in
clade C2, FII_AJ851089, was also clade associated, being found
predominantly in clades A (13/25 isolates, 52%) and C1 (41/57,
72%) rather than B (12/51, 24%) andC2 (8/82, 10%) (P 0.0001,
Fisher exact test) (see Fig. S3). Overall, this strongly suggests the
ancestral acquisition of the FII_AY458016 replicon within clade
C2, its associationwith blaCTX-M-15 and the expansion of the clade,
TABLE 1 Plasmid replicon families/types by clade
Inc type
No. of isolates (row %) for clade:
Total no. of
isolates
Difference in replicon
prevalence across
clades, PA/H41 B/H22 C1/H30R C2/H30Rx
A/C 1 (33) 1 (33) 1 (33) 3 1
B/O/K/Z 1 (10) 2 (20) 2 (20) 5 (50) 10 0.9
FIA only 1 (50) 1 (50) 2 1
FIA total 15 (10) 1 (0.7) 52 (36) 77 (53) 145 <0.001a
FIA-FIB 3 (100) 3 0.07
FIA-FII 4 (9) 39 (91) 43 <0.001
FIA-FIB-FII 15 (15) 1 (1) 44 (45) 37 (38) 97 <0.001
FIB only 2 (100) 2 0.12
FIB total 25 (16) 43 (28) 47 (30) 40 (25) 155 <0.001
FIB-FII 8 (22) 25 (69) 3 (8) 36 <0.001
FIB-FIC-FII 2 (12) 15 (88) 17 <0.001
FIC total 2 (12) 15 (88) 17 <0.001
FII only 4 (67) 1 (17) 1 (17) 6 0.12
FII total 25 (13) 45 (23) 49 (25) 80 (40) 199 0.02
H 5 (100) 5 0.001
I 4 (25) 6 (38) 3 (19) 3 (19) 16 0.09
N 2 (15) 7 (54) 4 (31) 13 0.15
P 2 (100) 2 0.12
Q 1 (11) 7 (78) 1 (11) 9 0.005
R 1 (100) 1 0.36
X-like 7 (58) 2 (17) 3 (25) 12 0.06
Y 1 (8) 1 (8) 2 (17) 8 (67) 12 0.25
a Boldface indicates statistically significant differences (P 0.05).
Stoesser et al.
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its evolution in the presence of FIA-FIB replicons, and its sporadic
loss.
Plasmid transformants demonstrate similarities and differ-
ences in blaCTX-M-15 plasmids from ST131 clades and other se-
quence types. Sequence data were generated for 30 transformed
blaCTX-M plasmids (denoted ashost isolate name _T; relevant
source strains are labeled “T” in Fig. 1): four from clade A, con-
taining blaCTX-M-15 (n 1), blaCTX-M-14 (n 2), and blaCTX-M-27
(n  1); one from clade B, containing blaCTX-M-55; three from
clade C1, containing blaCTX-M-14 (n 2) and blaCTX-M-24 (n 1);
20 from clade C2, containing blaCTX-M-15; and two blaCTX-M-15
plasmids from non-ST131 isolates (see Table S2 in the supple-
mental material). The mean percent pairwise differences in plas-
mid sequence between all plasmid pairs were compared with the
divergence times of the corresponding host strains. This demon-
strated that all transformed blaCTX-M plasmids shared at least 10%
homology but could be genetically divergent (Fig. 4), plasmids
found in different STs could be very similar (up to ~90% sequence
homology), and plasmid genetic similarity correlated with host
strain divergence time for recently diverged host strains (up to
~30 years) but was much more variable for more remotely di-
verged host strains.
Most transformed blaCTX-M plasmids were IncF, except in two
cases (11B00320_T and la_7619_T). BLASTn-based comparisons
revealed that the clade A blaCTX-M-15 IncI plasmid (11B00320_T;
isolated in Mae Sot, Thailand-Myanmar border) was circulating
in a limited fashion (Fig. 5) but with substantial sequence homol-
ogy to blaCTX-M-15-containing contigs from the two other clade A
blaCTX-M-15-positive isolates (JJ2591,Minneapolis, MN, USA, and
AZ779845, Spain). Although we did not have transformants or
specific plasmid sequences for these, the blaCTX-M-15-containing
contig assembled for JJ2591was 88,693 bp long and very similar to
the 11B00320_T assembly, whereas the AZ779845 blaCTX-M-15-
containing contig was 32,228 bp long and likewise highly similar
in structure (Fig. 5). These data suggest that an IncI-CTX-M-15
plasmid is responsible for sporadic, horizontal introductions of
blaCTX-M-15 into ST131 with a wide geographic distribution.
Nineteen of 20 transformed blaCTX-M-15 plasmids from clade
C2 contained an FII_ AY458016-like replicon, supporting the as-
sociation of IncFII_AY458016 with blaCTX-M-15. Sequence com-
parisons among 17 (of 20 total) plasmids from clade C2 that con-
tained IncFII_AY458016 identified a significant degree of
homology (Fig. 6) (excluding 8A16G_T, 11B01979_T, and
19B19L_T; see Materials and Methods). However, only eight
coding sequences were shared with 100% nucleotide similarity,
including blaCTX-M-15, blaOXA-1, aac(6’)-Ib-cr, a glucose-1-
phosphatase-like-enzyme, a CAAX amino-terminal protease self-
immunity protein, a hypothetical phage protein, and a pemI/
pemK plasmid addiction system. This lack of gene conservation
suggests that significant genetic exchange and rearrangement oc-
cur among these plasmids as they evolve within the subclade.
Genetic comparisons among the transformed blaCTX-M-14/14-like
plasmids revealed that three shared strikingly similar genetic
structures, two of which (uk_8A9B_T, Oxford, United Kingdom,
and cam_1071_T, Siem Reap, Cambodia) were identified in clade
A, in host strains with a TMRCA within the last 15 years, and one
in clade C1 (la_5108_T, Vientiane, Laos) (Fig. 7). BLASTn-based
comparisons across all 215 ST131 sequences demonstrated that
many isolates in clades A (predominantly subcluster [i]) and C1
apparently contained stretches of highly similar genetic struc-
tures, as did small numbers of isolates in clade C2 (Fig. 7).
11B01979_T (Mae Sot, Thailand-Myanmar border), a trans-
formed blaCTX-M-15 plasmid in clade C2, also showed significant
homology to uk_8A9B_T, cam_1071_T, and la_5108_T (Fig. 7),
suggesting that both blaCTX-M-14 and blaCTX-M-15 variants can be
accommodated on the same plasmid background.
The isolates containing blaCTX-M-55 and blaCTX-M-24 (one-SNV
derivatives of blaCTX-M-15 and blaCTX-M-14, respectively) appar-
ently resulted from discrete plasmid acquisition and/or blaCTX-M
transposition events within ST131 (see Fig. S4 in the supplemental
material). These were not therefore shown to represent blaCTX-M
evolution within established blaCTX-M-15 or blaCTX-M-14 plasmid
backgrounds.
DISCUSSION
Our WGS analysis of the largest (n 215) and most diverse col-
lection of ST131 isolates to date establishes that the global emer-
gence of drug-resistant clades (C1/H30, C2/H30Rx) occurred ap-
proximately 25 years ago, most likely in a North American
context and consistent with strong selection pressure exerted
by the widespread introduction and use of fluoroquinolones
and extended-spectrum cephalosporins. Interestingly, this ap-
FIG 4 Mean pairwise percent difference between all transformed plasmid
sequence pairs plotted against time to most recent common ancestor
(TMRCA) for the two strains hosting the respective transformant plasmids.
Red circles indicate pairs where both strains are in C2; blue triangles indicate
pairs where one or both strains are outside C2. The lower panel represents the
same data but limited to strains with a TMRCA of less than 30 years.
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pears to be at odds with the previous observation that ESBLs
predominating in North America in the 1990s and early 2000s
were mostly blaTEM or blaSHV variants (23); however, the stud-
ies summarized in this review were mostly undertaken in nos-
ocomial and/or critical care settings, investigated non-E. coli
Enterobacteriaceae, used phenotypic screening methods that
may have missed the emergence of blaCTX-M in E. coli (e.g.,
higher extended-spectrum cephalosporin breakpoints, focused
FIG 5 (Top) BLASTn-based comparison across the ST131 data set, using the blaCTX-M-15-containing 11B00320_T as a reference. Color represents degree of presence/
absenceof identity to the 11B00320_T sequenceonan isolate-by-isolate basis per row.Rows/isolates are arranged as in theFig. 1 phylogeny. (Bottom)ProgressiveMauve
alignment of 11B00320_T and the CTX-M-15-containing contigs for two other isolates in clade A. Alignments with substantial homology are represented as similarly
colored blocks (“locally collinear blocks”); white regions within these blocks represent low homology. Vertical red lines represent contig breaks.
Stoesser et al.
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on beta-lactam/beta-lactamase inhibitor-resistant isolates), or
did not test specifically for blaCTX-M variants.
Although members of each ST131 clade have dispersed glob-
ally, our data indicate that within specific geographic regions,
smaller clonal ST131 outbreaks occur at all genetic levels (gene,
flanking context, plasmid, and host strain), supporting the hy-
pothesis that both horizontal gene transfer and clonal expansion
have contributed to the global dissemination of this sequence
type. The estimated molecular evolutionary rate of ST131 (1.00
mutation per genome per year) is similar to previous estimates
from ST131 (24) and the species overall (25), strongly suggesting
that ST131’s epidemiological success is not due to a higher-than-
average mutation rate.
Our study shows that the apparent persistence of particular
blaCTX-M variants within specific ST131 clades is due to diverse
mechanisms. These include (i) acquisition of a blaCTX-M-
FIG 6 ProgressiveMauve alignment of assembled contigs, ordered with respect to pP46212, for 17 blaCTX-M-15 FII plasmids derived from sequenced transfor-
mants, all in clade C2/H30Rx. Plasmids are ordered with respect to the position of their host strains in themain phylogeny (except pP46212 [Fig. 1]). Alignments
with substantial homology are represented as colored blocks (“locally collinear blocks”) and are linked with colored lines; white regions within these blocks
represent low homology.
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containing plasmid by a specific host strain subcluster, followed
by evolution and spread across geographic regions (e.g., clade A
blaCTX-M-14 subcluster [i] [Fig. 6; see also Fig. S2 in the supplemen-
tal material]); (ii) multiple discrete acquisition events involving
blaCTX-M-containing plasmids (e.g., blaCTX-M-55 and blaCTX-M-24
[see Fig. S4]; different blaCTX-M-14 clusters); (iii) horizontal trans-
fer of common plasmid structures across clades (e.g., the IncI
blaCTX-M-15 plasmid [Fig. 5]); and (iv) chromosomal integration
of blaCTX-M and evolution by descent (e.g., blaCTX-M-15 [Fig. 2];
blaCTX-M-14). Despite this high degree of genetic plasticity, we also
FIG 7 (Top) BLASTn-based comparisons across the ST131 data set, using the blaCTX-M-14-containing uk_8A9B_T as a reference. Color represents degree of
presence/absence of identity to the uk_8A9B_T sequence on an isolate-by-isolate basis per row. Rows/isolates are arranged as in the Fig. 1 phylogeny. (Bottom)
ProgressiveMauve alignment of uk_8A9B_T, cam1071_T, la_5108_T, and 11B01979_T, with the last three ordered using uk_8A9B_T as a reference and contig
boundaries represented as vertical red lines. Alignments with substantial homology are represented as colored blocks (“locally collinear blocks”); white regions
within these blocks represent low homology. Vertical red lines represent contig breaks.
Stoesser et al.
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found clear structuring of blaCTX-M variants and plasmid content,
with the near-complete absence of blaCTX-M in clade B and asso-
ciations of blaCTX-M-14/14-like variants with clade A and clade C1/
H30R, of blaCTX-M-15 with clade C2/H30Rx, and of specific com-
binations of IncF replicons with certain clades. This supports the
hypothesis that some plasmid replicons are acquired and persist
stably within clades. Although the evolutionary dynamics of
plasmid-host combinations remain to be clearly elucidated, co-
evolution of host and plasmid in the case of C2/H30Rx appears to
have ameliorated costs to the host and facilitated persistence of the
replicon (26, 27), with ongoing conjugative exchange of genetic
material. The relative contribution of changing environmental in-
fluences on this coevolution is unclear; it may also be affected by a
host-plasmid “arms race” in a microevolutionary version of the
“Red Queen Hypothesis” (antagonistic coevolution) (28, 29).
The almost ubiquitous presence of blaCTX-M-15 in clade C2/
H30Rx is most striking and is strongly associated with the pres-
ence of an IncFII_AY458016-like replicon. Previous smaller stud-
ies have found that blaCTX-M-15 is frequently part of a 2,971-bp
ISEcp1-blaCTX-M-15-ORF477 transposition unit, with blaCTX-M-15
located 48 bp downstream of the ISEcp1 IRR-R, and that this is
commonly nested within a Tn2 element (30). One hypothesis is
that an IncFII_AY458016 ancestral plasmid was acquired by a
fluoroquinolone-resistant C1 host strain approximately 25 years
ago and subsequently incorporated one of these blaCTX-M-15 trans-
position units. In response to the widespread clinical use of
extended-spectrum cephalosporins and fluoroquinolones, the
C2/H30Rx clade has expanded, andwithin it, blaCTX-M-15 has been
mobilized through further transposition events (e.g., to the chro-
mosome) and rearrangement/recombination among IncFII-like
plasmids, much of this associated with IS26 (31) (Fig. 3). The
persistence of the IncFII_AY458016-like replicon in C2 may be
attributable, at least in part, to its association with a plasmid ad-
diction system (pemI/pemK) (32), whereas its ongoing evolution
is potentially linked to the concomitant presence of FIA/FIB rep-
licons on blaCTX-M-15 plasmids (see Fig. S3 in the supplemental
material) (33). Alternative hypotheses could be envisioned, e.g.,
multiple, clade C2-restricted acquisitions of different blaCTX-M-15-
containing FII_AY458016-like plasmids or recurrent ISEcp1-
blaCTX-M-15-ORF477 unit acquisitions. These seem less likely,
however, because (i) there are no geographic or major genotypic
distinctions between clades C1 and C2 to explain why this would
occur, (ii) there is a degree of homology in the flanking contexts
around the gene throughout the clade, and (iii) flanking context/
transformed plasmid structures also appear to be consistent
within C2 subclusters.
Our novel comparison of transformed, sequenced plasmids
demonstrates that a substantial degree of similarity can exist
among blaCTX-M plasmids found in different clades and STs. This
indicates that between-clade/ST transfer of these resistance plas-
mids occurs and that care is needed when inferring plasmid evo-
lution by descent (Fig. 4). The observed plasmid similarity across
geography in the context of host strain phylogenetic clustering
and homology in regions flanking blaCTX-M (as demonstrated
here) is much more likely to represent ancestral plasmid acquisi-
tion and subsequent evolution by descent rather than multiple
acquisition events but still needs to be interpreted with caution, as
it may, for example, represent exposure to a common, global,
plasmid reservoir.
The study has several limitations. First is the inability with
short-read sequencing and limited transformant sequencing to
assess fully the flanking regions and plasmid structures across the
entire data set. In particular, the BLASTn-based heat maps across
the wider data set represent not genetic contiguity of plasmid
structures within isolates as such but instead overall plasmid se-
quence presence/absence. Second, results from de novo assemblies
of these short-read data also must be interpreted cautiously, as
these assembly methods are known to increase the number of
SNVs compared with mapping-based approaches and may result
in misinterpretations of genetic structures, particularly repetitive
regions (34). Third, again relating to the limitations of short-read
data, the transformant plasmid sequences comprise multiple con-
tigs, precluding certainty as to the plasmids’ exact structure. More
extensive future use of long-read sequencing (e.g., PacBio) could
help resolve this. Fourth, many of our H30Rx/C2 clade trans-
formed CTX-M plasmids were from a single United Kingdom
center; however, the genetic flanking contexts identified here have
also been found in plasmid sequences from other national and
international locations (30, 35, 37), suggesting that these are dis-
persed more widely and that our results are likely generalizable.
In summary, our analysis strongly suggests that the emergence
of the C2/H30Rx clade within ST131 has been driven by the ac-
quisition of a specific FII plasmid, which has subsequently under-
gone major genetic restructuring within its globally dispersing
bacterial host. The initial acquisition event occurred approxi-
mately 25 years ago, possibly associated with the widespread clin-
ical introduction of extended-spectrum cephalosporins and fluo-
roquinolones, which would have exerted significant selection
pressure for persistence of chromosomal fluoroquinolone muta-
tions and presence of blaCTX-M. Sporadic gain/loss events involv-
ing other, non-FII blaCTX-M-15 plasmids have also occurred but
have not dominated. Similar processes may be driving the more
recent emergence of sublineages of ST131 with blaCTX-M-14 and
blaCTX-M-27, as described in Japan (36), although for blaCTX-M-14,
these appear to have occurred on at least two occasions (clades A
andC1/H30R [Fig. 1]). This study highlights the global imperative
to reduce antimicrobial selection pressures; the capacity of these
resistance plasmids for genetic reassortment; the important role of
certain insertion sequences, such as IS26, in facilitating horizontal
mobility of resistance determinants; and the possibility of target-
ing specific replicons in an attempt to limit the spread of impor-
tant resistance gene mechanisms.
MATERIALS AND METHODS
Sample collection, sequencing, and sequence read processing. Isolates
were obtained from wider collections held in several centers: the Shoklo
Malaria Research Unit, Mae Sot, Thailand; the Lao-Oxford-Mahosot
Hospital Wellcome Trust Research Unit, Vientiane, People’s Democratic
Republic of Laos; the Cambodia-Oxford Medical Research Unit, Angkor
Hospital for Children, Siem Reap, Cambodia; and the Microbiology Lab-
oratory, Oxford University Hospitals NHS Trust, Oxford, United King-
dom. No two isolates were taken from the same individual. In addition,
seven isolates collected from clinical samples across Canada between 2006
and 2008 and one isolate recovered from poultry in 2006 were included.
DNA was extracted as previously described (38). Sequence data for the
eight AstraZeneca strains had been generated from a series of isolates
collected by International Health Management Associates, Inc., as part of
a global resistance survey; the data for the Price strains were as previously
described (13). Sequencing was performed using either the Illumina
HiSeq or the MiSeq sequencer (100- or 151-bp paired-end reads [details
for non-Price strains are in Table S1 in the supplemental material]). Se-
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quence type was confirmed using BLASTn-based (39) in silicomultilocus
sequence typing (MLST) of de novo-assembled WGS data (40).
Properly paired sequence reads were mapped using Stampy v1.0.17
(without Burrows-Wheeler Aligner premapping, using an expected sub-
stitution rate of 0.01) to a fully sequenced E. coli ST131 reference (E. coli
O150:H5 SE15; RefSeq NC_013654), in order to limit bias introduced by
mapping to amore divergent reference. Repetitive regions (166,828 bases,
3.5%) of the referencewere identified using self-self BLASTn analysis with
default settings; these regions were then masked prior to mapping and
base calling. Single-nucleotide variants (SNVs)were determined across all
mapped nonrepetitive sites using SAMtools (version 0.1.18) mpileup.
mpileupwas run twice to separate high-quality base calls from low-quality
base calls: first, with options “-E -M0 -Q25 -q30 -m2 -D -S” and otherwise
default settings, and second, with options “-B -M0 -Q0 -q0 -m2 -D -S”
and otherwise default settings. Vcf files of annotated variant sites were
created using GATK (v1.4.21). Base calls derived from these two Vcf files
were then retained only if (i) the proportion of high-quality bases sup-
porting the call was90%, and5 high-quality bases were required as a
minimum; (ii) the root of the mean square mapping quality of reads
covering a putative variable site was 30; (iii) the Phred scaled quality
supporting a base call was 25; and (iv) reads spanning the putative
variable site weremade up of35%high-quality bases. Core variable sites
(base called in all sequences, excluding “N” or “-” calls) derived from
mapping to the SE15 reference were “padded” with invariant sites in a
proportion consistent with the GC content and length of the reference
genome (4.72 Mb, 51% average GC content), to generate a modified
alignment of input sequences for our phylogenetic analyses (see below).
De novo assemblies were generated using Velvet with the Velvet-
Optimiser wrapper (n  211) (41) (http://bioinformatics.net.au/soft-
ware.velvetoptimiser.shtml) or A5-MiSeq (42). The latter was used in
cases where the number of assembled bases was below the expected as-
sembly size of 4 to 5.5 Mb (n  4 [strains la_12107_3, can_70883,
can_1731_01, and can_1070] in which the median optimized assembly
size with Velvet was 16,004 bases and the median number of contigs was
only six). Using A5-MiSeq, assemblies for these four strains were gener-
ated with an appropriate median size of 5,143,908 bp and 269 contigs.
Identification/characterization of blaCTX-M and genetic context,
gyrAmutations, andfimH typing.BLASTn analysis of de novo assemblies
was used to identify: (i) blaCTX-M presence and variants (in-house refer-
ence gene database) (38); (ii) genetic context for blaCTX-M, by extracting
and annotating contigs containing blaCTX-M variants using PROKKA and
ISFinder (manual annotation) (43, 44); (iii) chromosomal gyrA muta-
tions in the quinolone resistance-determining region known to be re-
sponsible for conferring most resistance to fluoroquinolones; (iv) fimH
presence and variant (45); and (v) Inc type using the downloaded Plas-
midFinder (46) and pMLST databases (available at http://pubmlst.org/
plasmid/) (47). Genetic contexts for blaCTX-M were classified as chromo-
somal if annotations for regions flanking blaCTX-M were found to be
consistently chromosomal in other E. coli strains in GenBank and plasmid
if these were associated specifically with plasmids (e.g., tra genes); other-
wise, they were classified as unknown. IncFII_AY458016-like sequences
were extracted, aligned, and visually inspected to confirm variant types
using Geneious (version 7.1.9; Biomatters Ltd., Auckland, New Zealand)
(48).
ST131 chromosomal phylogenetic comparisons using Clonal-
Frame, BEAST, and BASTA. ExPEC bacteria are recombinogenic and
contain recombination hot spots with higher-than-average recombina-
tion rates (49). Recombination can obscure the clonal phylogenetic signal,
and we therefore initially analyzed the alignment of sequences with Clon-
alFrame (50) to identify recombinant regions. Three separate runs were
performed on the alignment of ST131 sequences, with the following set-
tings: 2,000 burn-in iterations, 2,000 Monte Carlo Markov chain
(MCMC) iterations following the burn-in period, and 2 iterations be-
tween recording parameter values in the posterior sample (the thinning
interval). Convergence of the runs was assessed by comparing the simi-
larities of the run outputs. SNVs within regions identified as recombinant
from the consensus ClonalFrame output were ignored in the subsequent
BEAST/BASTA analyses.
Using themodified alignment of ST131 sequences generated following
the ClonalFrame analysis, mutation rate estimates across ST131 and a
time-scaled phylogeny were calculated in BEAST (51). Themodel param-
eters were (i) a generalized time-reversible nucleotide substitutionmodel;
(ii) four relative rates of mutation across sites, allowing for all sites to be
subject to mutation (i.e., the proportion of invariant sites fixed at 0%);
(iii) a strict molecular clock estimating a uniform evolutionary rate across
all branches of the tree; and (iv) a constant population size. Triplicate runs
with 30 million iterations were performed, with 10% discounted as burn-
in. Run convergence and mixing were assessed by inspecting the run log
files in Tracer v1.5 (http://beast.bio.ed.ac.uk); adequate convergence of
run statistics andmixing for each run and effective sample sizes (ESSs) for
all parameters greater than 200 were required for an analysis to be con-
sidered adequate, in line with recommendations in the BEAST tutorials
on the developers’ website (http://beast.bio.ed.ac.uk). We explored the
application of several other models in BEAST incorporating the relaxed
clock and variable population growth (exponential, logistic, and Bayesian
skyride), but these either failed to converge, showed poor mixing, or had
effective sample size (ESS) estimates of200 and were therefore not con-
sidered robust.
We used the phylogeographic method BASTA (20) in the Bayesian
phylogenetic package BEAST 2.2.1 (52) to infer patterns and rates of mi-
gration between geographical regions from the genome alignment, collec-
tion dates, and sampling locations. Initially, we grouped samples into
three discrete locations, North America, Southeast Asia, and Europe, and
disregarded samples from South America and Australasia because of the
small sample numbers. Due to the nonrandom sampling scheme, we es-
timated only a single effective population size, equal for all locations, and
a symmetric migration rate matrix. The analysis was run for 108 MCMC
steps. We subsequently reran the analysis including a fourth, unsampled
deme, using the same model parameters, to determine whether this al-
tered the outcome.
Plasmid transformations, sequencing, and analyses. Plasmid trans-
formants were generated from 30 strains chosen on the basis of tree
topology and association with CTX-M variants, aiming to transform at
least one plasmid from each of the major CTX-M variant clusters. Two
blaCTX-M-containing plasmids from non-ST131 E. coli (one ST617/
blaCTX-M-15 and one ST405/blaCTX-M-55) were also transformed and se-
quenced as an external comparison.
Plasmid DNA was extracted from subcultures of frozen stock grown
overnight on blood agar, followed by selective culture of a single colony in
lysogeny broth (BD/Difco LB broth; Miller [Luria-Bertani]; catalog no.
244620) with ceftriaxone at 1 g/ml. DNA extraction was performed us-
ing the Qiagen plasmid minikit (Qiagen, Venlo, Netherlands), in accor-
dance with the manufacturer’s instructions, with the addition of Gly-
coblue coprecipitate (Life Technologies, Carlsbad, CA, USA) to the DNA
eluates prior to isopropanol precipitation to enable better visualization of
the DNA pellet. Plasmid DNA was redissolved in distilled water and then
typically electroporated on the same day or stored in the refrigerator prior
to electroporation within 24 h.
Commercially prepared DH10B E. coli (ElectroMAXDH10B cells; In-
vitrogen/Life Technologies, Carlsbad, CA) was used as the recipient cell
strain for plasmid electroporation, because of its high transformation ef-
ficiency and the fact that the strain has been fully sequenced (NCBIRefSeq
NC_010473.1) (53). Electroporation was performed with a MicroPulser
electroporator (Ec2 settings). Transformant cell suspensions were cul-
tured on selective agar (Luria-Bertani agar plus ceftriaxone [1 g/ml]),
with appropriate controls.
Sequencing was performed on the Illumina HiSeq or MiSeq se-
quencer, generating 150- or 300-base paired-end reads (see Table S2 in the
supplementalmaterial). Sequencing reads from the isolate fromwhich the
transformed plasmid had been obtained were mapped back to the trans-
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formed plasmid assembly in order to ascertain the reliability of the assem-
bly in each case. Reads were assembled using A5/A5-MiSeq (42), and
assembled contigs were annotated with PROKKA (43). The median plas-
mid assembly size was 122,786 (range, 72,449 to 171,919), with a median
of 22 contigs in each assembly (range, 1 to 33). Using longer reads (300 bp;
MiSeq platform) resulted in a significantly smaller number of contigs per
assembly (median, 17 versus 25; rank sum P 0.003). Mapping was used
to assess the reliability of our plasmid constructs and reflected the content
present in each transformed and assembled resistance plasmid, with the
exception of 8A16G_T.
A single strain (P46212) from the data set was also sequenced using
long-read technology (PacBio); the CTX-M-15 plasmid (pP46212) from
this strain was assembled into a single, circularized contig as described
elsewhere (A. E. Sheppard, N. Stoesser, D. J. Wilson, R. Sebra, A. Kasar-
skis, L. W. Anson, A. Giess, L. J. Pankhurst, A. Vaughan, C. J. Grim, H. L.
Cox, A. J. Yeh, Modernising Medical Microbiology Informatics Group,
C. D. Sifri, A. S. Walker, T. E. A. Peto, D. W. Crook, and A. J. Mathers,
submitted for publication).
Plasmid content across the data set was investigated in a number of
ways. First, the transformed plasmid sequences that we generated were
used as references against which BLASTn-based comparisons for degree
of presence/absence were made for the whole data set. We used default
BLASTn settings to compare the de novo assembly for each ST131 isolate
with each respective, concatenated plasmid reference sequence. Sequence
identity of BLASTn hits across the plasmid reference was plotted using the
heatmap.2 package in R, with a minimum threshold of 90% identity for
plotting. For simplicity, values were averaged over 100-bp bins (script
available at https://github.com/aesheppard/plasmid_comp).
Second, comparisons between each pair of transformed plasmid as-
semblies were undertaken, again using BLASTn with default settings. For
the query sequence in each comparison, the percentage of sites contained
in hits (counting overlapping hits only once) was identified from parsed
blast output. For each pair, two percentage of homology statistics were
generated, taking each member of the pair as a reference in turn, to ac-
count for differences in length (script available at https://github.com/
aesheppard/plasmid_comp). The mean percent divergence for each plas-
mid sequence pair was then plotted against the time to most recent
common ancestor (TMRCA) of the two host strains containing those
transformed plasmid sequences (derived from the time-scaled tree) in
Stata (SE) (StataCorp, Texas, USA; version 11.2).
Third, for visualization, plasmid sequences were compared using Pro-
gressiveMauve (54), with assembled contigs reordered with respect to the
pP46212 PacBio-generated CTX-M-15 plasmid reference, using the
“Move contigs” tool. For this, three transformed plasmid sequences were
excluded: 8A16G_T because of issues surrounding the assembly,
11B01979_T because it was virtually identical to transformed blaCTX-M-14
plasmid sequences in clade A, and 19B19L_T because it lacked an FII
replicon. Finally, annotated, transformed plasmid sequences were clus-
tered using CD-Hit (55) [-c 1.0 -n 5 -d 0 -g 1], to identify whether any
coding sequences were shared and whether there might be any biological
significance associated with these on the basis of their annotations.
Sequencing data resources. The positions for called, variable sites
across the data set (with respect to the reference SE15 E. coli genome) are
listed in Text S1 in the supplementalmaterial, and the positions in recom-
binant regions (and therefore not included in the phylogenetic analyses)
are listed in Text S2. Contigs for the de novo assemblies for the trans-
formed plasmid sequences are in Text S3, and those for all the new isolates
are freely downloadable at http://modmedmicro.nsms.ox.ac.uk/stoesser-
n-et-al/.
Accession numbers. Sequencing data for the new isolates sequenced
for this study have been deposited in the NCBI Short Read Archive (Bio-
Project number PRJNA297860, 108 ST131 sequences and 30 blaCTX-M
plasmid transformants [see Tables S1 and S2 in the supplemental mate-
rial]). The uk_P46212 sequence assembled using PacBio is available from
GenBank (accession numbers CP013658 [chromosome] and CP013657
[CTX-M-15 plasmid]).
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